卵磷脂络合碘治疗中心性浆液性脉络膜视网膜病变  

Effects of Jolethin on central serous chorioretinopathy

作　　者：肖斯贤[1] 曾庆纯[1] 蔡可莉[1] 

机构地区：[1]汕头大学医学院第一附属医院眼科,广东汕头515041

出　　处：《中国基层医药》2004年第11期1316-1317,共2页Chinese Journal of Primary Medicine and Pharmacy

摘　　要：目的　观察卵磷脂络合碘治疗中心性浆液性脉络膜视网膜病变的疗效。方法　 4 2例经临床及荧光素血管造影 (FFA)确诊为中心性浆液性脉络膜视网膜病变患者随机分为两组 ,治疗组 2 3例 ,用卵磷脂络合碘 ,1 5mg/次 ,3次 /d ,共 2个月 ;对照组 19例 ,用肌苷片 ,2 0 0mg/次 ,3次 /d ,共 2个月。观察治疗前后视力、眼底变化、视野及FFA改变。结果　 1例淘汰。有效率治疗组 90 9% ,对照组 36 8% (P <0 0 1)。结论　卵磷脂络合碘对中心性浆液性脉络膜视网膜病变有明显疗效。Objective To investigate the effects of jolethin on central serous chorioretinopathy(CSC).Methods 42 patients with CSC diagnosed by clinic and fundus fluorescein angiography(FFA) were randomly divided into two groups.23 patients(23 eyes) as treatment group received jolethin three times a day for 2 months and 19 patients(19 eyes) as control group received inosine three times a day for 2 months.The changes of visual acuity,ophthalmoscopic sign,visual field and FFA before and after treatment were observed.Results 1 patients(1 eye) loss of follow up.The effective rate was 90.9% in the treatment group and 36.8% in the control group(P<0.01).Conclusion Jolethin has remarkable effects in the treatment of CSC.

关 键 词：中心性浆液性脉络膜视网膜病变 络合碘 治疗中 对照组 治疗组 FFA 卵磷脂 目的观 结论 视野 

分 类 号：R774.1[医药卫生—眼科]